BSECompany Update1d ago · 26 Oct 2026, 06:23 pm

Conference call for Analysts and Investors to discuss the un-audited financial results of the Company for the quarter and half year ended September 30, 2026 on Tuesday, November 03, 2026 at 04:00 p.m. (IST)

Advanced Enzyme Technologies Ltd · 540025

✦ AI SummaryResults

Advanced Enzyme Technologies Ltd will host a conference call on November 3, 2026, to discuss its un-audited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

c16ccedc-ef75-4164-9dac-a8c85f146ff6.pdf

pdf

Download →
View document text
cfrancec/ enzymes WhoreENZYMEisLife AdvancedEnzymeTechnologiesLtd. CIN:L24200MH1989PLC051018 SunMagnetica,Awing,5thFloor,LICServiceRoad,Louiswadi,Thane(W)-400604,India Tel:+91-22-41703200,Fax:+91-22-25835159 Email:info@advancedenzvmes. com, www.advancedenzymes. October 26, 2026 BSE Limited National Stock Exchange of India Ltd. Department of Corporate Affairs Exchange Plaza, Plot No. C/1, G Block P. J. Towers, Dalal Street, Bandra-Kurla Complex, Bandra (E) Mumbai- 400 001 Mumbai- 400 051 Scrip ID-540025 Scrip Code-ADVENZYMES Dear Sir, Sub: Intimation of conference call to discuss Un-audited Financial Results for the quarter and half year ended September 30, 2026 under the SEBI (Listing Obligations and Disclosure Requirements) Regulations Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we would like to inform that the Company will host a conference call for Analysts and Investors to discuss the un-audited financial results of the Company for the quarter and half year ended September 30, 2026 on Tuesday, November 03, 2026 at 04:00 p.m. (IST) as per the details provided in the Annexure. The aforesaid information is also being uploaded on the website of the Company. Thanking you, Yours Faithfully, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head – Legal Encl.: As above Factory:PlotNo.A-61/62,MIDCMalegaon,Tal.Sinnar,Dist.Nashik-422113.Maharashtra.India.Tel.:+91-9970100750/+91-2551-230044,Fax:+91-2551-230816 Mancecl enzymes WhereENZYMEisLite MANAGEMENTWILLBEREPRESENTEDBY: Advanced Enzyme Technologies Limited Mr.MukundKabra Mr.Beni Prasad Rauka Whole-timeDirector ChiefFinancialOfficer willhost a conference call for analysts andinvestors to discussthe financial resultsfor theQuarter & Half year ended 30th September 2026 CONFERENCEDIAL-INNUMBERS Please dialthenumbers at least 5 -10minutesprior tothe conferencescheduleto ensurethat youareconnectedto your Tuesday 16:00 callintime 03rdNovember 2026 Hours 1ST Primary Number:+91 22 6280 1403 / +91 22 7115 8304 USA:18667462133|UK:08081011573|Singapore:8001012045 HongKong: 800964448 | Canada:01180014243444 Pre-register to REGISTRATIONLINK avoid wait time: RSVP AdvancedEnzymeTechnologiesLimited £ AdvancedEnzymeTechnologiesLimited Q Regd.Office:5thFloor,'A'Wing,SunMagnetica,Louiswadi, Mr. Ronak Saraf | Investor Relations Thane(W)- 400604 | Tel.:+912241703200 S.3 ir@advancedenzymes. com (fy Website:www.advancedenzymes.com V +918657864146 ala CINNo:L24200MH1989PLC051018